Sorry, you need to enable JavaScript to visit this website.

DAURISMO™ (glasdegib) Indications and Usage

1 INDICATIONS AND USAGE

DAURISMO is indicated, in combination with low-dose cytarabine, for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adult patients who are ≥75 years old or who have comorbidities that preclude use of intensive induction chemotherapy.

What's New

No Current Announcements.

Search

Please enter your search term(s) for DAURISMO™